Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Jan 6, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-01-04

Reporting Person: ELAN CORP PLC (10% Owner)
Reporting Person: ELAN INTERNATIONAL SERVICES LTD (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-01-04	Common Stock	S	950	$1.81	Disposed	12063932	Indirect
2005-01-04	Common Stock	S	1400	$1.80	Disposed	12062532	Indirect
2005-01-04	Common Stock	S	6400	$1.78	Disposed	12056132	Indirect
2005-01-04	Common Stock	S	20690	$1.77	Disposed	12035442	Indirect
2005-01-04	Common Stock	S	3800	$1.76	Disposed	12031642	Indirect
2005-01-04	Common Stock	S	24500	$1.75	Disposed	12007142	Indirect
2005-01-04	Common Stock	S	7591	$1.72	Disposed	11999551	Indirect
2005-01-04	Common Stock	S	1750	$1.71	Disposed	11997801	Indirect
2005-01-04	Common Stock	S	77919	$1.70	Disposed	11919882	Indirect
2005-01-05	Common Stock	S	10200	$1.80	Disposed	11909682	Indirect
2005-01-05	Common Stock	S	14465	$1.76	Disposed	11895217	Indirect
2005-01-05	Common Stock	S	225335	$1.75	Disposed	11669882	Indirect

Footnotes

F1: These securities are or were beneficially owned indirectly by Elan Corporation, plc ("Elan") and directly by its wholly-owned
subsidiary, Elan International Services, Ltd. ("EIS").